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Abstract
HEY bHLH transcription factors have been shown to regulate multiple key steps in cardiovascular development. They can be
induced by activated NOTCH receptors, but other upstream stimuli mediated by TGFß and BMP receptors may elicit a
similar response. While the basic and helix-loop-helix domains exhibit strong similarity, large parts of the proteins are still
unique and may serve divergent functions. The striking overlap of cardiac defects in HEY2 and combined HEY1/HEYL
knockout mice suggested that all three HEY genes fulfill overlapping function in target cells. We therefore sought to identify
target genes for HEY proteins by microarray expression and ChIPseq analyses in HEK293 cells, cardiomyocytes, and murine
hearts. HEY proteins were found to modulate expression of their target gene to a rather limited extent, but with striking
functional interchangeability between HEY factors. Chromatin immunoprecipitation revealed a much greater number of
potential binding sites that again largely overlap between HEY factors. Binding sites are clustered in the proximal promoter
region especially of transcriptional regulators or developmental control genes. Multiple lines of evidence suggest that HEY
proteins primarily act as direct transcriptional repressors, while gene activation seems to be due to secondary or indirect
effects. Mutagenesis of putative DNA binding residues supports the notion of direct DNA binding. While class B E-box
sequences (CACGYG) clearly represent preferred target sequences, there must be additional and more loosely defined
modes of DNA binding since many of the target promoters that are efficiently bound by HEY proteins do not contain an E-
box motif. These data clearly establish the three HEY bHLH factors as highly redundant transcriptional repressors in vitro and
in vivo, which explains the combinatorial action observed in different tissues with overlapping expression.
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Introduction
NOTCH signaling is a key regulatory pathway for cardiovas-
cular development and homeostasis [1]. Its receptors mainly act
through transcriptional activation of target genes by a complex of
the NOTCH intracellular domain, released by gamma-secretase,
the transcription factor CBF1 (RBP-Jk) and the Mastermind co-
activator proteins (Maml1-3). Without NOTCH binding CBF1
has a repressive function and associates with additional co-
repressor proteins. Upon activation different and in part cell type
specific target genes are induced, the most prominent ones
encoding members of the HEY and HES family of bHLH
repressor proteins. There are three HEY genes (HEY1, HEY2 and
HEYL) and several HES genes, with HES1 being the closest
relative. All are related to the Drosophila hairy and Enhancer-of-split
genes, which are well known transcriptional repressor proteins.
HEY and HES proteins have a similar domain architecture with a
DNA binding and dimer-forming bHLH (basic helix-loop-helix)
region, an Orange domain that may also participate in dimeriza-
tion and conserved C-terminal WRPW (HES) or YRPW (HEY)
motifs. The WRPW peptide mediates interactions with groucho-
type co-repressor proteins, but YRPW interaction partners for
HEY proteins are still unknown.
Mouse knockout studies have revealed a striking overlap in
phenotypes between NOTCH and HES or HEY mutants suggesting
that these bHLH factors convey a significant fraction of the known
biological responses [1,2]. Loss of HEY2 or HEY1/HEYL leads to
identical cardiac phenotypes with ventricular septum defects
(VSD) and valve anomalies that appear to be due to an impaired
EMT process of endocardial cells in the atrioventricular canal [3].
Since HEY1 and HEYL single knockouts do not show evidence of
cardiac developmental defects these genes are obviously less
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expression and the overlap in phenotypes clearly argue for a
combined and partially redundant action of all three HEY genes.
Interestingly, there is also a cooperation of HEY1 and HEYL in
skeletal muscle since double knockout mice lack quiescent satellite
cells, which are essential for regeneration [4]. When HEY1 and
HEY2 are deleted together a much earlier embryonic vascular
defect is observed with failure of angiogenic remodeling and a lack
of arterial differentiation [5,6]. Additional critical sites for HEY
functions are the inner ear [7], brain [8] and bone [9]. The
apparent redundancy of HEY factors in many sites and their high
degree of sequence identity in the bHLH region suggest that they
may be functionally interchangeable, but there are also claims for
a completely different function of HEYL e.g. in neurogenesis [10].
Evidence for this scenario is limited, however.
Despite extensive analyses of mouse phenotypes surprisingly
little is known about the direct targets of HEY or HES genes [2].
Microarray analyses of overexpressing cells or tissues from
knockout animals have provided evidence for HEY dependent
changes in gene expression in several settings [11–14]. There is
very little overlap between target lists, however, and evidence for
direct regulation of these genes by HEY proteins is largely lacking.
To better characterize the network of genes that mediate
NOTCH-HEY signaling effects in target cells we generated
HEK293 cells that express HEY1, HEY2 or HEYL in a highly
regulatable fashion. These cells were used to search for HEY-
dependent changes intranscript levelsby microarray analysis and to
identify direct binding sites of all three HEY factors in target genes.
We could define putative binding motifs and validate DNA targets
by promoter analysis. Analysis of cardiac tissue from knockout mice
validates a number of these genes as direct in vivo targets.
Results
Target gene identification in cells with regulatable HEY
genes
To identify target genes of HEY factors we employed HEK293
cells with tightly regulated HEY transgene expression. HEK293
cells were chosen since they express endogenous HEY genes at
significant levels ensuring that these cells are capable of responding
appropriately. According to transcript profiling HEY1 ranks as
number 525 of all expressed genes, while HEY2 and HEYL are
expressed at lower levels with a rank of around 10.000 [15]. To
generate a system with tunable HEY gene expression, cells were
first transfected with pWHE134 [16], encoding a reverse
tetracycline transactivator (rtTA) plus a tetracycline-dependent
repressor (tetR-KRAB) driven by a CMV promoter (293tet cells).
Flag-HA-(FTH)-tagged HEY1 and Flag-HEY2 sequences under
the control of a tetracycline-responsive promoter were subse-
quently introduced via lentiviral vectors (for details see Materials
and Methods and Figure S1A–S1D). For some of the experiments
Flag-Strep-(FS)-tagged constructs were employed with similar
results using transposon-mediated insertion (FS-HEY1, FS-HEY2,
and FS-HEYL). The N-terminal epitope tags do not affect
localization or transcriptional activity of the proteins in vitro.
Western Blot analysis and quantitative RT-PCR of individual
clones confirmed tightly regulated doxycycline (Dox)-dependent
expression (Figure S1E). Experiments were either conducted with
30–50 ng/ml Dox for low level expression (e.g. raising endogenous
HEY1 mRNA level by 2–10 fold) or with 1–2 mg/ml Dox for
stronger overexpression.
HEY regulated genes were identified after strong induction for
48 h (293tet-FTH-Hey1) or 72 h (293tet-Flag-Hey2), respectively,
using Affymetrix microarrays. Under more stringent cut-off values
only a small number of genes appeared regulated. With relaxed
criteria of $1.36 similar numbers of up- and down-regulated
genes were identified (Figure 1A and Table S1). The number of
target genes and the extent of regulation were greater for HEY2,
which may result from differences in protein levels due to longer
induction, differential potency of the bHLH protein or cell-
intrinsic mechanisms. Comparison of gene lists identified a strong
overlap, but in all cases the span of regulation is small.
Validation of microarray results was done by quantitative real-
time RT-PCR (qRT-PCR) on a subset of genes (Figure 1B).
Repression could generally be confirmed and the extent of
regulation tended to be higher, in the range of 2–6-fold. For
upregulated genes validation was also successful in most cases, but
the extent of regulation was more limited. Importantly, values
obtained for HEY1 and HEY2 were more similar now, likely due to
the same 72 h induction period. Especially for repressed genes the
longer induction time may lead to larger changes since the half-life
of target mRNAs becomes less of a problem. Expression of the
endogenous HEY1 as well as HEY2 and the related HES1 gene was
repressed, pointing to a negative feedback loop for these factors.
These experiments were repeated for HEK293 cells with a
regulated expression of Flag-Strep-tagged HEYL and all the genes
tested exhibited very similar direction and extent of regulation.
Thus, the three HEY factors appear functionally interchangeable,
at least in HEK293 cells.
Since HEK293 cells express endogenous HEY1 this may already
lead to a repression at baseline. We therefore tested expression of
target genes in a HEY1 knockdownsituation. Using stably expressed
shRNA we managed to reduce HEY1 RNA expression by 75%.
Even this rather limited reduction had a clear impact on target
genes expression (Figure 1B). SeveralHEY-repressed genes wereup-
regulated up to 3.4-fold (BMP2), while at least some of the genes
induced upon HEY overexpression tended to be repressed by HEY1
knock-down, further confirming the validity of our target genes.
Transcription and development as GO terms
Gene ontology analysis of regulated genes identified a striking
overrepresentation of genes related to transcriptional control as
Author Summary
NOTCH signaling is a central developmental pathway that
influences a multitude of cell fate decisions and differen-
tiation steps as well as later tissue homeostasis and
regeneration. The three HEY genes encode basic helix-
loop-helix transcription factors that are critical effectors to
convey signaling by NOTCH receptors and similar signaling
systems. This is underscored by the multitude of develop-
mental defects observed in HEY single- and double-mutant
mice. The mode of action of HEY proteins remained largely
unexplored, however. By gene expression analysis and
chromatin immunoprecipitation we have now identified a
large set of HEY target genes. While only 500–2,000
mRNAs are regulated by HEY1 or HEY2, there are around
10,000 binding sites in the genome. HEY proteins act as
transcriptional repressors that bind close to transcriptional
start sites in all cases tested. In contrast, gene activation
seems to be mediated by indirect/secondary mechanisms.
The extent of regulation is rather limited, implicating HEY
genes in modulating rather than switching on or off target
gene expression. All our in vitro and in vivo data point to a
high degree of redundancy between the three HEY genes,
suggesting that tissue specific patterns and expression
levels determine the final outcome of HEY induced cellular
responses.
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prevalence of transcriptional control genes suggests that HEY
genes are positioned higher up in the hierarchy of signaling
cascades and modulate other transcription factors rather than
effector genes. The terms identified for morphogenetic processes
include limb/skeletal development, neurogenesis, organogenesis of
branching organs (kidney, lung), cardiac and vascular develop-
ment, which agrees with the dynamic spatio-temporal HEY
expression patterns in embryos and implicates HEY genes in a
broad spectrum of developmental decisions. For HEY1, apoptosis-
related genes are over-represented especially among upregulated
genes. However, most of the strongly enriched GO terms are
preferentially found for down-regulated genes, indicating that they
form a more focused group. These also tend to exhibit higher
ratios of expression changes, which is in agreement with the
primarily repressive nature expected for HEY bHLH factors.
Hey proteins directly bind their target promoters
The mode of HEY action has been questioned by publications
implicating indirect mechanisms of transcriptional control despite
the presence of a classical bHLH domain [summarized in 2].
Especially the lack of E-box target sequences in some of the few
known HEY-repressed genes has cast doubt on direct DNA
binding as the mode of action. We therefore tested four strong
target genes (HEY1, KLF10, BMP2 and FOXC1) in HEK293 cells
for direct HEY binding by chromatin immunoprecipitation
(ChIP). 293tet-FTH-Hey1 cells were induced at low level to avoid
oversaturation and HEY-bound DNA was captured using a Flag-
antibody. In each case sequences from the proximal promoter
region (within 2 kb of the transcriptional start site (TSS)) were
efficiently enriched (10- to 60-fold) in Dox-induced cells (see also
Figure 2D). Controls with non-induced cells or immunoprecipi-
tations using unspecific IgG antibodies were both negative,
demonstrating high specificity. Other conserved sequences further
upstream (21.4 to 26.5 kb from TSS) or intronic regions were
not enriched. Experiments with HEY2 and HEYL (not shown)
generated essentially the same results, indicating that HEY
proteins bind to the proximal promoter regions of target genes
in a similar, if not identical fashion.
Further support for direct DNA binding came from experiments
with a subtle HEY1 mutant, where conservative point mutations
were introduced at three sites in the basic domain, which alter
Figure 1. HEY target gene validation and gene ontology analysis. (A) Number of down- and upregulated genes from microarray analysis of
HEK293 cells after induction of HEY1 or HEY2. (B) Real-time RT-PCR validation of gene regulation by inducible HEY1, HEY2, HEYL expression and upon
HEY1 knock-down (shRNA). Shown is the fold change between the induced and uninduced state. Note that microarray probes and real-time PCR
primers only recognize the endogenous HEY transcripts. In the overexpression situation total HEY1, HEY2 and HEYL were .220 fold induced
compared to endogenous levels. (C) GO term analysis was performed to identify biological processes enriched among HEY1 and HEY2 regulated
genes ($1.3 fold). The top 14 annotation clusters are shown according to their cluster enrichment score [2lg(mean p-value)]. Cluster names are
based on enriched GO annotations. ‘‘U’’ indicates the corresponding value for upregulated and ‘‘D’’ for down regulated genes.
doi:10.1371/journal.pgen.1002728.g001
Targets of Hey bHLH Repressors
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R62K; HEY1-RK3) (Figure 2). The mutant protein was expressed
at similar levels upon Dox induction, it exhibits nuclear
localization and it efficiently dimerizes with wild-type HEY1 (not
shown). Expression analysis of the target genes HEY1, KLF10,
BMP2 and FOXC1 revealed that only wild-type HEY1, but not
HEY1-RK3 is capable of repression (Figure 2C). In ChIP analysis
HEY1-RK3 did not bind to the corresponding target promoters
(Figure 2D). Thus, the basic domain and its presumptive DNA
contacting side chains are essential for the transcriptional activity
of HEY1.
ChIPseq analysis for HEY1 and HEY2
Since HEY proteins can directly bind to promoters of target
genes we sought to identify the complete repertoire of potential
HEY regulated genes through next-generation sequencing of
ChIP-enriched DNA fragments (ChIPseq). Non-induced cells were
used as a reference. A total of 13–14 million reads were generated
for HEY1 and HEY2 and around 90% of these could be mapped
back to the human genome (Tables S2, S3, S4). In both cases
approximately 10,000 high confidence binding sites could be
identified (criteria being a p-value of ,10
25 and a peak height of
$10). To validate candidate genes of HEY1 and HEY2, we tested
peaks from 23 genes with different height (11 to 380) individually
by quantitative PCR (Figure S2). Each binding site could be
validated and the same DNA regions were also found to be targets
of HEY2 (not shown).
Characteristics of HEY binding sites
HEY1 and HEY2 exhibit a remarkable similarity of binding
profiles and in most cases peaks of ChIP-enrichment are
superimposable (Figure 3A). When binding sites are ranked,
59% of the top 1000 sites are shared between HEY1 and HEY2. A
further 37% of these sites are still among the top 5000 binding sites
of the other factor, respectively (Figure 3B). Thus, only a small
minority of binding sites (<4%) may be divergent between HEY1
and HEY2 and upon manual inspection most of these are small
peaks or the divergence is only of technical nature. The strong
similarity of binding is also evident from the heat map generated
for all HEY peaks, where very similar distributions of peaks are
evident and potential differences seem to be limited to low-scoring
sites (Figure 3C).
Binding sites are preferentially located in the proximal promoter
region of genes or within exon 1: 55–62% of all peaks are within
500 bp of transcriptional start sites (TSS) and 66–76% fall within
+/22 kb (Figure 4A). When the strictly intragenic peaks were
counted more than one third each is located in exon 1 or in intron
1, respectively (Figure 4B). This suggests that HEY proteins likely
act directly on promoter associated protein complexes and not
through long range enhancer or silencer type mechanisms. The
vast majority of binding sites (.90%) are located within CpG
islands. This is especially true for peaks within +/22 kb of the
TSS (98%) and to a lesser extent for more distal peaks (75%).
HEY binding sites are located preferentially at active or poised
promoters exhibiting H3K4me3 histone marks. In HEK293 cells
approximately 20.000 promoters are characterized by the
presence of Pol II [15] and the histone mark H3K4me3 [17].
Around one third of these sites is also bound by HEY1 or HEY2,
representing around 70% of all Hey peaks (Figure 4C). In contrast,
there is no evidence at all for HEY binding at silent promoters that
lack Pol II/H3K4me3 marks. HEY bound active promoters have
somewhat reduced average H3K4me3 values, which may
correspond to the repressive capacity of HEY proteins. Gene
Ontology analysis of the top 1000 peaks revealed that the
promoters bound by HEY proteins are strongly biased towards
transcriptional control and embryonic development genes
(Figure 4D). This corresponds well to the data obtained from
the microarray analyses described above.
Figure 2. Mutation of putative DNA contacting amino acids in the HEY1 basic domain inactivates its function. (A) Amino acid sequence
of the HEY1 basic domain and the HEY1-RK3 mutant with three amino acid exchanges (R50K, R54K, R62K) that likely contact DNA bases. (B)
Immunostaining of transfected HEK293T cells with a Flag antibody confirms a preferential nuclear localization of Flag-tagged HEY1 and HEY1-RK3. (C)
Real-time RT-PCR shows repression of HEY1, BMP2, KLF10 and FOXC1 by HEY1, but not by HEY1-RK3 (log scale). (D) ChIP analysis confirms enrichment
of HEY1 binding sites in target promoters by wild type HEY1, but not by mutant HEY1-RK3 (log scale).
doi:10.1371/journal.pgen.1002728.g002
Targets of Hey bHLH Repressors
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The striking similarity of HEY1 and HEY2 binding patterns
posed the question whether HEYL has the same preferences. This
is clearly the case for genes used for ChIPseq validation, listed in
Figure S2 (data not shown). Preliminary analysis of ChIPseq data
from induced 293tet-FS-HEYL cells revealed that the vast
majority of HEY1/2 bound sequences are again bound by HEYL
(95% of Hey1/2 peaks, Table S5). We also identified a large
number of additional binding sites that tend to be barely present
and/or not significant in the analysis of HEY1 and HEY2 (Table
S5). HeyL was expressed at somewhat higher levels compared to
Hey1/2, which may contribute to the detection of additional,
previously not significant peaks. On the other hand, we have little
evidence to major changes in Hey binding when cells were
induced at lower or higher levels or even transiently transfected.
Therefore the basis for the increase in binding sites for HeyL will
have to be clarified in future studies before final conclusions can be
drawn. Nevertheless, all three HEY proteins appear to bind to the
same core of genomic sites with very similar preferences.
HEY binding motifs
To identify potential DNA binding motifs for HEY1 or HEY2
we searched the top 300 target sites (+/2100 bp of peak location)
using bioinformatic tools. Sequence motifs that are overrepresent-
ed tend to be highly GC-rich since the average GC content in
HEY peak regions is around 85%. To reduce the influence of this
bias we carefully selected control regions from a set of promoters
that are not bound by HEY factors, but display very similar GC
profiles. Using the motifRG package we identified two motifs that
resemble E-box sequences (Figure 5A). Through binding site
selection we had previously identified a class B E-box motif
(CACGTG/CACGCG) as a preferred HEY binding site [18],
which turned out to be one of the two sequences in our list. One
other sequence (GCGCGC) reached a similar score, but its
relevance remains unclear.
Electrophoretic mobility shift assays with purified HEY1 protein
expressed in E.coli showed strong E-box binding (CACGTG) and
efficient competition by the unlabeled oligonucleotide (Figure 5B).
The related CACGCG and CGCGCG sequences were much
Figure 3. HEY1 and HEY2 have overlapping DNA binding characteristics. (A) ChIPseq profiles for HEY1 and HEY2 are highly similar
(examples visualized by the UCSC genome browser). (B) Venn diagram showing the overlap between the top 1000 and top 5000 peaks for HEY1 and
HEY2. (C) K-means clustered heat maps of the HEY1 and HEY2 signals at all peak locations (peak summit +/2500 bp), showing three clusters with
common peaks and one cluster each with weaker HEY1 versus HEY2 peaks and vice versa.
doi:10.1371/journal.pgen.1002728.g003
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competed by an excess of the prototypic class B site. Nevertheless,
only a fraction of Hey peaks contain the CACGYG E-box
sequence, suggesting that in vivo binding may employ an even
more relaxed consensus or depend on additional interacting
proteins.
Luciferase assays of target genes
Promoter analysis with luciferase reporter assays validated
HEY-dependent repression in vitro. In transient co-transfections
several promoters like HEY1, JAG1, BMPR1A and NGN3 were
efficiently repressed by cotransfection of HEY1 (Figure 6).
Transfection of an activator construct encoding a fusion of the
HEY1 bHLH-Orange sequences with the VP16 activation domain
(VP16-HEY1) in turn induced luciferase expression from the same
reporter. The HEY1-RK3 protein with its impaired DNA binding
capacity was incapable of efficient repression or activation. Each
promoter contains at least one sequence motif that could serve as a
HEY binding sequence. In the case of JAG1 a targeted mutation of
the putative E-box motif (gggCACGCGtca to gggCAtca) fully
Figure 4. HEY peaks are clustered at transcription start sites of active promoters with a preference for developmental and
transcriptional regulatory genes. (A) Histograms show the number of HEY1 and HEY2 peaks within a certain distance to the closest transcription
start site (TSS) of the human hg19 refseq genome. Quartiles indicate the window around the median distance containing 50% of all peaks. (B) Pie
charts identify main peak locations within genes. (C) K-means clustered heat maps of ChIPseq signals in HEK293 cells for HEY1, HEY2, uninduced
control, RNA polymerase II (PolII) and histone-3-lysine-4-trimethylation (H3K4me3). Graph includes all hg19 refseq TSS (+/21 kb). (D) GO term analysis
identifies enriched biological processes among genes with high HEY1 and HEY2 peaks (top 1000 peaks according to height). The top annotation
clusters are shown according to their cluster enrichment score [2lg(mean p-value)]. Cluster names are based on enriched GO annotations.
doi:10.1371/journal.pgen.1002728.g004
Targets of Hey bHLH Repressors
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demonstrates that HEY proteins directly bind DNA through E-
box motifs and mediate repression of their target genes.
Hey-repressed genes have strong HEY binding sites
Comparison of target lists for gene regulation and DNA binding
further supports the concept of HEY proteins as direct repressors.
Especially the genes with stronger repression on mRNA level
frequently had ChIP peaks close by and peak height was much
higher (median 27 and 22) (Figure 7). Importantly, genes that were
induced upon HEY expression did not have significant associated
ChIP peaks (median peak height 0). This underscores the notion
that repression of transcription appears to be a direct effect of HEY
proteins on the corresponding promoters, while gene induction
rather tends to be a secondary and indirect phenomenon.
Validation of HEY target genes in vivo
Hey genes are important for development of several organ
systems including the heart as reported in numerous knockout
studies. We therefore aimed to validate our HEY target genes in
the mouse heart. To confirm the presence of HEY binding sites at
corresponding genomic locations we repeated our ChIP experi-
ments in HL-1 cells, a murine cardiomyocyte cell line, which
maintains cardiac morphology and biochemical and electrophys-
iological properties in cell culture [19]. We were able to confirm
16 out of 18 HEY binding sites (Figure 8A), indicating that the
majority of HEY binding sites detected in HEK293 cells are also
present in murine cardiomyocytes.
Hey2 and Hey1/L knockout mice exhibit membranous VSDs and
valve defects and overlapping expression in the critical endocardial
cells of the AV canal [3,20]. Hey2 knockout hearts in addition show
evidence of cardiomyopathy in the ventricles, which corresponds well
to the fact that ventricular cardiomyocytes express only Hey2,b u tn o t
Hey1 or HeyL. We therefore tested dissected ventricles of Hey2
2/2
embryos at E14.5 for deregulation of Hey target genes. A series of
genes tested exhibited a clear and highly significant up-regulation in
knockout embryos by quantitative real-time RT-PCR (Figure 8B). In
contrast, Hey1 and HeyL are not expressed in the ventricles and in the
knockout situation there is only limited deregulation of the same set of
genes where only induction of Sema6d reaches statistical significance.
To extend these findings we also tested ventricles from animals with a
global Hey1 over-expression [9]. In this case, most of the genes up-
regulated in Hey2
2/2mice were down-regulated (Figure 8B) with the
lower amplitude likely being due to endogenous Hey2 already being
present. This clearly documents that Hey repression of target genes is
functional in the mouse in vivo with an induction of these genes in the
knockout situation.
Discussion
The strong phenotypes of Hey knockout mice raised the
question of potential target genes that may mediate the effects
Figure 5. HEY binding motifs identified in silico are bound by HEY proteins in electrophoretic mobility shift assays. (A) The two top
motifs for DNA binding by HEY1 identified by de-novo motif discovery using the R package motifRG, based on 200 bp sequences at the summit of
the 300 highest HEY1 peaks and 300 matched control sequences with similar GC-content and TSS-distance. (B) Recombinant MBP-HEY1 protein
interacts with CACGTG. Binding of the biotin labeled CACGTG probe is competed increasingly by 5-, 15- and 50-fold molar excess of unlabeled
CACGTG, CACGCG and CGCGCG-probes. The latter are the least effective. Shifted oligonucleotide indicated by arrow.
doi:10.1371/journal.pgen.1002728.g005
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characterized the genome-wide regulatory potential of HEY
proteins by performing microarray gene expression analysis
combined with ChIPseq to identify all potential HEY binding sites.
HEY factors only modulate gene expression
HEY genes have been described as repressors of a small number
of individually tested target genes that had been identified
serendipitously by various means [summarized in 2]. To search
for additional HEY regulated genes we chose HEK293 cells as
these are easy to manipulate and they express endogenous HEY
genes suggesting that they can react to altered HEY protein levels
in a physiologically relevant manner. We obtained very similar
patterns of expression changes for HEY1 and HEY2, both on
microarrays as well as in confirmatory real-time RT-PCR. Even
the more divergent family member HEYL led to concordant
regulation of the target genes tested. Surprisingly, the level of
regulation was rather limited in all cases. HEY1 itself is the
strongest down-regulated gene (3–6-fold), indicative of an impor-
tant negative feedback loop. For HEY2 and HEYL the repression
was also seen, but less pronounced. This negative feedback loop
may be similar to the ones described for Hes1 and Hes7 that are
important in somitogenesis and neural stem cell biology [21]. The
generally modest expression changes suggest that HEY genes
rather modulate existing gene transcription instead of completely
switching expression states. On the other hand, preexisting HEY1
mRNA and protein in HEK293 cells may already induce a level of
repression that can be further enhanced to a limited extent only
and this is supported by our experiments with Hey1 shRNA,
where an induction of several target genes could be seen. The
study by Xin et al. [13] likewise reported a small number of HEY2
regulated genes, where only three structural genes showed
regulation in the range of 5–9-fold, which is in line with our data.
HEY factors redundantly bind to many target sites
Gene regulation on mRNA level could be due to direct or
indirect effects of HEY proteins on target promoters. This
distinction became more relevant as HEY proteins led to induction
and repression of comparable numbers of transcripts. ChIP
analyses are an excellent tool to generate additional evidence for
Figure 6. Functional analysis of HEY target promoters. HEY1 ChIPseq signal for the (A) JAG1 (B) NEUROG3, (C) BMPR1A and (D) HEY1 genes.
Orange lines indicate the closest potential HEY binding motif under the peak summit. Open boxes indicate the fragment used in the luciferase assay.
For JAG1 a second luciferase construct with a mutated binding site was used (JAG1-Mut, deleted nucleotides underlined). (E) Schematic
representation of different HEY1 variants used to determine the effect of HEY1 on luciferase-promoter constructs: VP16-HEY1-bHO (HEY1-bHLH-Or
inserted after VP16 activator domain), HEY1-RK3 (HEY1 with mutant basic domain). (F) Luciferase reporter analysis in HEK293 cells transiently
transfected with reporter-constructs (JAG1, JAG1-Mut, BMPR1A, HEY1 and NEUROG3) and HEY expression plasmids or empty vector control (set at 1).
Induction/repression was determined from triplicate measurements.
doi:10.1371/journal.pgen.1002728.g006
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limited overexpression of HEY genes in order to still mimic a
physiological situation. Nevertheless, we identified a very large
number of around 10,000 target sites in HEK293 cells with almost
identical profiles for HEY1 and HEY2. Differences are mostly
restricted to less enriched target sites. This translates to a Pearson’s
correlation of r=0.75 between HEY1 and HEY2, which is close to
the value of r=0.83 obtained for biological replicas in other
studies [22], indicating that HEY1 and HEY2 regulate the same
targets. For HEYL an even larger number of peaks was identified.
While the reason for the increased number of binding sites is still
unclear, the vast majority of HEY1 and HEY2 peaks were again
seen in our HEYL dataset, supporting the idea of strongly
overlapping functions.
There is a striking discrepancy, however, between the large
number of ChIP peaks and the much smaller number of genes
regulated by HEY proteins. The vast majority of binding sites
observed may thus not contribute to gene regulation, or else
endogenous HEY proteins may have already exhausted the
regulatory potential at some of these sites. On the other hand,
an overabundance of bound DNA sequences has been observed
for other transcription factors before, like the bHLH factors MYC
or MYOD that yielded comparable results [23,24]. Given the
probably limited protein concentration it even appears question-
able if all sites will be occupied simultaneously in any given cell
and rather points to a high turnover rate. For c-MYC, another E-
box binding protein, a two-step model of initial binding to open
chromatin followed by more relevant sequence specific binding
has been put forward [25]. Functionally active binding sites may
also emerge only through additional modifications or concomitant
binding of additional factors to form fully functional complexes. A
possible scenario to explain HEY functions might therefore
include a general preference of HEY factors for genes with an
open chromatin configuration, where the actual transcriptional
change then depends on circumstances like cell type and
differentiation status. It remains to be established if and how
HEY functions can be described by such models.
HEY proteins act as direct repressors
The mode of regulation by HEY proteins appears to be rather
uniform. The vast majority of binding sites were found in close
proximity to transcriptional start sites. This rather implicates HEY
proteins in direct interactions with the basal transcriptional
machinery or local chromatin at promoters as opposed to long
range enhancer type mechanisms. The majority of HEY-repressed
genes appears to be direct targets since they contain strong HEY
binding sites within the promoter or 59 UTR regions. On the other
hand, genes activated by HEY proteins are likely regulated in an
indirect manner: more than half of them do not contain relevant
peaks at all and peak height was generally rather small, suggestive
of HEY expression leading to a reduction in other critical
transcriptional activators for those genes.
Direct repression of target promoters could also be verified in
vitro by luciferase reporter assays. As reported in earlier studies by
us and others, HEY1/2/L can repress target promoters up to ten-
fold [14,26]. Our current experiments provide important addi-
tional evidence for a HEY function as direct transcriptional
repressor: Firstly, the bHLH-Orange domain can be turned into
an activator of transcription when fused to the strong VP16
activation domain. Furthermore, changing only three arginine
residues that presumably contact DNA into lysine completely
abolished DNA binding and transcriptional response of this
mutant. This clearly establishes HEY proteins as direct DNA
binding transcriptional repressors, while gene activation by HEY
proteins appears to be indirect as the promoters are largely devoid
of HEY target sites.
HEY proteins target E-box sites
A putative DNA binding motif for HEY proteins of tggCAC-
GYGcca has previously been defined by in vitro oligonucleotide
selection [18]. However, in most studies the core consensus E-box
site CACGYG was either not present in the small number of
putative target promoters analyzed previously, or deletion of
related E-box sites did not alter expression of luciferase reporter
constructs [summarized in 2], leading to proposals of indirect
HEY functions. Here we could show that deletion of an E-box site
in the JAG1 promoter abolishes HEY regulation in luciferase
assays. Related findings have recently been published for the IDE
promoter [27]. This shows that at least for some HEY target genes
the E-box motif is required for Hey regulation. De novo motif
discovery in our ChIPseq data set also led to the identification of
an E-box motif of CACGYG as one of the two top candidates.
Finally, a search of all known DNA binding motifs likewise
recovered myc-type E-box sequences as being highly enriched (not
shown). While these data clearly demonstrated that E-box
sequences can be bound by HEY proteins in vivo, this does not
fully explain the genomic binding patterns observed since many of
the bound regions do not contain such motifs. HEY proteins may
either use less stringent criteria for DNA binding in vivo or they
might also bind in a sequential manner that initially does not fully
rely on sequence specificity as suggested by Perna et al. [25].
Another possibility would be the need for additional cooperating
Figure 7. HEY-regulated genes have strong HEY binding sites.
Boxplots depict the peak height at HEY1/2 up- and down-regulated
genes ($1.3-fold). On average only down-regulated genes exhibit
strong peaks. P-values for a two-sided t-test are given. Shown are also
the total number of regulated genes and the number of regulated
genes with peaks.
doi:10.1371/journal.pgen.1002728.g007
Targets of Hey bHLH Repressors
PLoS Genetics | www.plosgenetics.org 9 May 2012 | Volume 8 | Issue 5 | e1002728factors that bind in the vicinity or form ternary complexes to
ultimately affect gene expression, but this will depend on the
characterization of novel HEY binding partners. The observed co-
occurrence of binding sites for factors like SP1, E2F, AP2, NRF
and EGR is expected at promoter-proximal regions, but may also
hint at potential interactions of HEY proteins with some of these
factors.
HEY factors only bind on active and poised promoters
The rather limited extent of gene repression by HEY proteins is
also reflected in the chromatin signature of the corresponding
promoters. There is a striking overlap of HEY bound sequences
with the presence of polymerase II (Pol II) and the active chromatin
mark H3K4me3, which are preferentially found at active and
poised promoters. This again argues in favor of a modulatory role of
HEY proteins with just limited alterations in gene expression. In
human ES cells Pol II and H3K4me3 marks have been identified at
silent genes as well, however, and it has been suggested that the
critical step lies in transcription elongation. Interestingly many
developmental regulators fall within this group of genes [28,29], to
which a significant fraction of HEY target genes belongs as well.
The location of a large number of HEY binding sites just
downstream of the transcriptional start site would ideally position
HEY to influence the pausing vs. elongation switch of Pol II.
Figure 8. In vivo validation of HEY target genes. (A) Enrichment of Hey1 and Hey2 target sequences from HL-1 cardiomyocytes by ChIP upon
transfection with Hey expression vectors compared to EGFP controls. Flanking DNA regions (negative controls) for Hey1, Hey2, Id2 and Nr2f2 were
not enriched. (B) Real-time RT-PCR results for cardiac ventricles from Hey2
2/2, Hey1
2/2/HeyL
2/2 and Hey1 over-expressing (Act-Hey1) E14.5 mouse
embryos. Shown is the fold change induction in knockout relative to the wild-type tissue. All genes have HEY-binding peaks identified by ChIPseq.
Significant induction is indicated by asterisks (p,0.05 *; p,0.005**).
doi:10.1371/journal.pgen.1002728.g008
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Previous studies have suggested redundancies between HEY1,
HEY2 and HEYL that manifest in distinct phenotypes in single and
combined KO mice due to partly overlapping expression profiles
[3,5,6]. The striking overlap in gene regulation and the highly
related patterns of ChIPseq peaks indicates that all three HEY
proteins indeed elicit very similar responses in a given cell type. This
isconsistentwiththe ideathat the expressionpatternsofHEYfactors
largely define the outcome of knockout studies, whereby no
individual, intrinsicfunctionalproperties, but overalland cumulative
Hey expression levels would be critical. On the other hand, the
substantial divergence in the poorly conserved C-terminal half of the
proteins is suggestive of a significant potential for paralog-specific
functions that may yet have to be uncovered. The identification of
either fully shared or paralog-specific protein interaction partners of
HEY factors may help to shed light on this important issue.
Materials and Methods
Cell culture and generation of inducible cell lines
HEK293 cells were cultured in DMEM medium (PAN Biotech,
Aidenbach, Germany) containing 10% FCS, 50 U Penicillin and
50 mg/ml Streptomycin. 293tet cells were generated by transfec-
tion with PvuII linearized pWHE134 plasmid [16] using
polyethylenimine (3 mg DNA, 6 ml PEI per 6-well plate for 8 h)
followed by selection with 0.5 mg/ml G418. HEY expressing cells
were produced by lentiviral transduction of 293tet cells with p199-
FTH-hHey1-iEP, p199-Flag-mHey2-iEP constructs based on p199
plasmids [30] (for maps see Figure S1). For regulated HEYL
expression pTol2-FS-mHeyL-iEins-WHE carrying insulator se-
quences (HS4ins) and the complete tet-regulatory module from
pWHE459 [31] was introduced into HEK293 cells by Tol2-
mediated transposition with pKate-N/Tol2 [32] followed by
puromycin selection (1 mg/ml). The HEY1 knockdown was
generated by lentiviral transduction of HEK293 cell with shRNA
vectors (Open Biosystems clone ID V3LHS_404238). In all cases
individual colonies were picked and validated separately. The
HEY1-RK3 mutant was generated by PCR-mediated mutagenesis
using primers spanning the altered sites. All constructs were
verified by sequencing.
HL-1 cells were cultured in Claycomb medium (Sigma-Aldrich,
Munich, Germany) containing 10% FCS, 100 mM norepineph-
rine, 4 mM L-glutamine, 50 U Penicillin and 50 mg/ml Strepto-
mycin. For ChIP 5*10
6 HL-1 cells were transiently transfected
with 8 mg plasmid DNA using 100 ml Ingenio Buffer (Mirrus,
Madison, USA) and the Amaxa Nucleofector II electroporator
(program T-20, Lonza, Basel, Switzerland). After 48 h of culture,
cells were used for ChIP.
Mouse lines
Hey1, Hey2 and HeyL knockout lines have been described
before [3,5]. The Act-Hey1 transgenic line expressing Hey1 under
the control of the ß-actin promoter was obtained from M. Susa
(NIBR, Basel) [9].
RNA isolation
Total RNA was extracted either from cells or tissue samples using
TriFast (peqGOLD, Peqlab, Germany, Erlangen) according to the
manufacturer’s protocoland quantifiedbyOD260 nm measurements
using a spectrophotometer (NanoDrop ND 1000, Peqlab).
Microarray analysis
Total RNA of control and dox-induced cells (1–2 mg/ml
doxycycline for 48–72 h) was used for microarray analysis on
Human Genome U133 Plus 2.0 Gene Arrays (Affymetrix, Santa
Clara, CA). Labeling and washing were performed according to
the standard Affymetrix protocol. The arrays were scanned using a
GeneChip Scanner 3000 (Affymetrix). Data analysis and quality
control was done using different R packages from the Bioconduc-
tor project (www.bioconductor.org). Probe sets were summarized
using the RMA algorithm and resulting signal intensities were
normalized by variance stabilization normalization [33].
Quantitative real-time RT–PCR (qRT–PCR)
2 mg RNA were reverse transcribed using the Revert Aid First-
Strand cDNA synthesis Kit (Fermentas, Lithuania, Vilnius) with
oligo(dT) primers. qRT-PCR was performed with an iCycler
iQ5
TM Real-Time PCR Detection System (BioRad, USA,
Hercules). Primer sequences are listed in Table S6. Reactions
contained 1/50 of the cDNA reaction and PCR was performed
with annealing at 60uC and SybrGreen quantification. PCR
products were confirmed by melting curve analysis and agarose gel
electrophoresis. The housekeeping gene HPRT was used to
normalize expression levels. All measurements were performed at
least twice and mean values were calculated.
ChIP analysis
5*10
6 HEK293 cells were induced with 50 ng/ml doxycycline
for 48 h to obtain low level overexpression of HEY proteins. The
same amount of cells was kept uninduced as control. HL-1 cells
were transiently transfected with pCS2p-Flag-Hey1, pCS2p-Flag-
Hey2 [14] and pll3.7, which was used as control. Cells were
harvested as described earlier [34]. Briefly, the cells were fixed
with 1% paraformaldehyde for 10 min at room temperature.
Fixation was stopped by adding glycine to 0.2 M and cells were
washed three times with ice-cold PBS and harvested. All
subsequent steps were done at 4uC. The cells were lysed in cell
lysis buffer (50 mM Hepes-KOH pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1% TritonX-100, 0.1% Deoxycholate, 0.1% SDS) and
spun down. The resulting pellet of nuclei was lysed in nuclei lysis
buffer (cell lysis buffer containing 1% SDS) and sonicated using a
Digital Sonifier W-250 D (Branson Ultrasonics, USA, Danbury).
Debris was removed by centrifugation. For immunoprecipitation,
Chromatin was diluted five-fold with ChIP buffer (0.01% SDS,
1.1% TritonX-100, 1.1 mM EDTA, 20 mM Tris pH 8.0,
167 mM NaCl) and 550 ml of diluted chromatin was mixed with
45 ml 1:1 protein G agarose slurry (in cell lysis buffer) and 4 mg
antibody (aFlag-M2 or rabbit IgG, Sigma-Aldrich) and incubated
overnight. Then, the agarose beads were washed three times with
cell lysis buffer, once with washing buffer (50 mM Hepes-KOH
pH 7.5, 350 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.1%
Deoxycholat, 0.1% SDS) and once with LiCl washing buffer
(10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5%
Nonidet P-40, 0.5% SDS). Elution was performed with elution
buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1% SDS) at 68uC for
30 minutes. The eluted chromatin was incubated with 0.8 mg/ml
Proteinase K and PFA fixation was reversed by incubation at 68uC
overnight. The DNA was then purified using phenol-chloroform
extraction, precipitated and quantified using PicoGreen (Invitro-
gen, USA, San Diego).
ChIPseq
For ChIPseq the same protocol as for ChIP was used in
principle, but 2.5*10
8 cells were employed and after lysis of nuclei,
chromatin was spun down at 20.000 rpm (SW 41 TI rotor,
Beckman, USA), washed twice with cell lysis buffer and sonicated
in 1 ml cell lysis buffer per 100 ml chromatin pellet. For ChIP
10 mg antibody was used. 7–12 ng of ChIP DNA was subjected to
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ration kit (New England Biolabs, Ipswich, USA) according to the
manufacturer’s instruction. Briefly, DNA was end-polished with
T4 DNA polymerase and kinase. After column purification,
Illumina adaptors were ligated to the ChIP DNA fragments. For
HEY1 and HEY2 fragments were subjected to 15 cycles of PCR
amplification and DNA with a length of 200–350 bp was excised
from an agarose gel using Qiagen gel extraction kit. For HEYL
175–225 bp fragments were first excised and then amplified by 18
cycles of PCR. The DNA fragments were sequenced on an
Illumina GAIIx platform (Illumina, USA, San Diego). 36 bp
sequences were generated and mapped to the hg19 genome by
bowtie 0.12.7 [35] with standard parameters. These raw
sequencing data were further analyzed using the peak finding
algorithm MACS 1.4.1 [36] using sequences from uninduced cells
as control to identify the putative binding sites. All peaks with a
minimum p-value of 10
25 and a minimum height of 10 were
included. The uniquely mapping locations for each factor were
used to generate the genome-wide intensity profiles, which were
visualized using the USCS genome browser. PeakAnalyzer [37]
was used to annotate peaks and to calculate overlaps between
different bed files. Heat maps were generated using seqMiner 1.2.1
[38] with K-means raw clustering.
GO term analysis
GO terms analysis was performed with DAVID 6.7 [39] using
the functional annotation clustering method and allowing only
biological processes. Clusters were named based on interpretation
of enriched GO annotations.
De novo motif discovery
The R-package motifRG (Bioconductor package motifRG,
Zizhen Yao, manuscript in preparation) was used to identify
binding motifs, using sequences +/2100 bp around the summit of
the top 300 highest ranking peaks. Unrelated sequences with a
similar distance towards transcription start sites of genes lacking
ChIPseq peaks and with similar GC distribution were selected and
used as control/background.
Mutation of JAG1 luciferase construct
The JAG1 luciferase construct containing the potential Hey
binding sequence tgaCGCGTGccc was mutated by cutting with
MluI (ACGCGT, Fermentas), followed by Mung Bean Nuclease
(Fermentas) treatment and religation using T4 DNA ligase
(Fermentas). This results in a four base pair deletion.
Luciferase assay
For luciferase assays approximately 10
4 HEK293 cells were
transiently transfected with 250 ng of the luciferase promoter
construct and 50 ng of the regulatory HEY construct in a 24-well
format. Cells were harvested after 48 h and lysed in 150 ml lysis
buffer (25 mM Glycyl-Glycine pH 7.8, 15 mM MgSO4,1 5m M
KPi, 4 mM EGTA, 1 mM DTT, 1% Trition-X100). After
incubating for 10 min at room temperature cells were pelleted
and 50 ml of the supernatant were measured in a GLOMAX 96
microplate luminometer (Promega, USA, Madison) using 150 ml
assay buffer (lysis buffer with, 1 mM ATP, 0.1 mg/ml D-Luciferin).
All measurements were done in triplicates.
EMSA
EMSA was performed using binding buffer (20 mM Tris
pH 7.6, 100 mM KCl, 0.5 mM EDTA, 0.1% Nonidet P-40,
1 mM MgCl2, 1 mM DTT, 10% glycerol) and 1 ng recombinant
MBP-HEY1 protein, 1 mg poly-dAdT, 5 ng biotin-labeled probe
and either 0, 25, 75 or 250 ng competing unlabeled probe in a
total volume of 10 ml. After incubating on ice for 30 min, samples
were loaded on a 6% polyacrylamide gel and later blotted onto
Amersham Hybond N+ membranes (Amersham, UK). Detection
was done using the PIERCE LightShift Chemiluminescent EMSA
kit according to the manufacturer’s recommendations (PIERCE,
USA, Rockford).
Immunofluorescence
HEK293T cells were transfected with either HEY1 or HEY1-
RK3 expression plasmids 24 hours prior to fixation with 4% PFA.
After blocking with 5% goat serum/0.3% Triton X-100/PBS, the
Flag antibody (rabbit; Cell Signaling, Danvers, Massachusetts) was
added (1:800; o/n, 4uC). After washing in PBS at RT the
secondary antibody Alexa488-rabbit (Bio-Rad) was used (1:2000;
1 h, room temperature). Nuclei were stained using Hoechst33342
(1:10000; Roth, Karlsruhe, Germany) and subsequently cover
slides were mounted in Mowiol. Pictures were taken using a Leica
AF6000 fluorescence microscope.
Usage of public data
The ENCODE ChIPseq data for H3k4me3 was downloaded
from ‘‘ftp://encodeftp.cse.ucsc.edu/pipeline/hg19/wgEncodeUwHistone/’’
(Producer: University of Washington) [17] and the ChIPseq data
for PolII was downloaded from ‘‘http://www.ncbi.nlm.nih.gov/
gds?term=GSE11892’’ [15].
Supporting Information
Figure S1 HEY expression vectors and expression controls.
Maps of vector constructs used to create stable HEY expressing cell
lines. For HEY1 (A) and HEY2 (B) lentiviral vectors containing
Flag-Strep (FS) tagged HEY1 or HEY2, respectively, under control
of a tetracycline responsive promoter (TRE-tight) were used. (C)
For HEYL a vector for transposon mediated insertion was used
containing Flag-Strep-tagged HEYL under control of a tetracycline
responsive promoter. (D) For HEY1 a lentiviral vector containing
Flag-TEV-HA tagged HEY1 was used in some experiments with
identical results. (E) HEY protein expression was verified by
Western Blot and real-time RT-PCR of stable cell lines. Cells were
harvested after induction with different doxycycline concentrations
for 48 h using standard SDS lysis buffers. Western blots on
nitrocellulose membranes were developed using the Flag-M2
antibody (Sigma-Aldrich) and anti-mouse-POD as a secondary
antibody (Chemicon, Millipore, Billerica, MA, USA) with
chemiluminescent detection. The fold induction compared to
endogenous HEY mRNA levels is shown for the concentrations
used for ChIP and RT-PCR experiments (the primers used here
amplify endogenous as well as transgene derived HEY transcripts).
The high induction seen for HEY2 and HEYL is due to the rather
low endogenous expression.
(TIF)
Figure S2 Validation of HEY1 ChIPseq data by quantitative
PCR. Shown is the fold enrichment of potential HEY1 binding
sites from promoter regions identified by ChIPseq compared to
non-induced control cells. Genes are ordered according to peak
height (from ChIPseq data) as indicated below. CCNB1 was used
as a negative control.
(TIF)
Table S1 Gene expression array data for HEY1 and HEY2.
Regulated genes ($1.36) from microarray experiments of
HEK293 cells with doxycycline inducible HEY1 (1 mg/ml dox
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sorted according to induced/uninduced ratio.
(XLSX)
Table S2 Statistics of ChIPseq analysis. ChIPseq data for
HEK293 with induced (+dox) and uninduced (-dox) HEY
expression were generated using the Illumina sequencing platform.
Reads were mapped against the human hg19 refseq genome using
bowtie with standard parameters. Peaks were identified using
MACS. The HEY2 uninduced control was also used as control for
HEY1.
(XLSX)
Table S3 ChIPseq peaks for HEY1. Shown are the locations of
all HEY1 ChIPseq peaks, by giving the start and the end point of
each peak as well as the summit position (location with highest
enrichment). tags=total number of reads attributed to peak;
pvalue=given as 210*log10(pvalue); fold=fold enrichment;
FDR=false discovery rate; height=peak height; TSS Distance=-
distance to closest transcription start site; given are also the
location and orientation of the Gene with the closest TSS.
(XLSX)
Table S4 ChIPseq peaks for HEY2. Shown are the locations of all
HEY2 ChIPseq peaks, by giving the start and the end point of each
peak as well as the summit position (location with highest enrichment).
tags=total number of reads attributed to peak; pvalue=given as
210*log10(pvalue); fold=fold enrichment; FDR=false discovery
rate; height=peak height; TSS Distance=distance to closest
transcription start site; given are also the location and orientation
of the Gene with the closest TSS.
(XLSX)
Table S5 ChIPseq peaks for HEYL. Shown are the locations of
all HEYL ChIPseq peaks, by giving the start and the end point of
each peak as well as the summit position (location with highest
enrichment). tags=total number of reads attributed to peak;
pvalue=given as 210*log10(pvalue); fold=fold enrichment;
FDR=false discovery rate; height=peak height; TSS Distance=-
distance to closest transcription start site; given are also the
location and orientation of the Gene with the closest TSS.
(XLSX)
Table S6 Sequences of all primers used.
(XLSX)
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